UPDATE: Credit Suisse Raises PT to $41 on HCA Holdings on Positive Reform Exposure
Credit Suisse maintained HCA Holdings (NYSE: HCA) with a Market Perform rating and raised the price target from $30.00 to $39.00.
Credit Suisse noted, "HCA reported 4Q12 EPS of $0.91, well ahead of consensus of $0.82 and ahead of our $0.89 estimate, driven by strong organic volume growth. The company also issued 2013 guidance that fell below consensus, which was not overly surprising. However, shares traded off early highs as mgmt provided somewhat reserved commentary around healthcare reform, pointing to many uncertainties that still exist, and the likelihood of a multi-yr ramp. We continue to believe reform will be a meaningful positive in 2014 and the 4Q results reinforce the strong market position and execution by HCA."
HCA Holdings closed at $37.51 on Tuesday.
Latest Ratings for HCA
|Jan 2017||PiperJaffray||Initiates Coverage On||Overweight|
|Nov 2016||Avondale Partners||Downgrades||Market Outperform||Market Perform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.